V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20112657 | 20088970 | 1.62 | null | null | 2018-02-20 | 2018-02-20 | Irinotecan | 02 | null | IBRUTINIB | 101839572 |
| 20112680 | 20088971 | 1.83 | 69.9 | Curative (C) | 2016-08-31 | 2016-09-01 | ECarboX | 02 | N | PLATO TRIAL | 101317419 |
| 20112952 | 20088972 | 1.7 | 49.8 | 03 | 2018-05-24 | 2018-06-14 | FCiSt | 02 | Y | CISPLATIN + TRASTUZUMAB | 101726390 |
| 20114236 | 20088974 | 1.6 | 81.9 | Adjuvant (A) | 2017-08-15 | 2017-08-15 | EVEROLIMUS | 02 | N | MUK8 TRIAL | 101696604 |
| 20115016 | 20088975 | 0 | 10.9 | Palliative (P) | null | 2016-10-29 | FEC 60 or 75 | 01 | N | ESPAC TRIAL | 100236967 |
| 20116066 | 20088976 | 1.82 | 57 | null | 2020-07-25 | 2020-08-08 | ARISTOTLE TRIAL | 02 | N | CAP + RT | 100522248 |
| 20116202 | 20088977 | 1.76 | 140.2 | Palliative (P) | 2019-12-31 | 2019-12-31 | BALLAD Trial | 02 | N | LENALIDOMIDE | 100342748 |
| 20116918 | 20088979 | 1.74 | 170 | Palliative (P) | 2019-03-05 | 2019-03-26 | Cytarabine Low Dose | 02 | N | SCOPE2 TRIAL | 100663476 |
| 20118797 | 20088982 | 1.55 | 50.7 | Adjuvant (A) | 2017-12-26 | 2017-12-26 | Carbo F | N | Y | GEMCITABINE + PACLITAXEL | 100817136 |
| 20119844 | 20088983 | 1.72 | 74 | Palliative (P) | 2017-07-07 | 2017-07-21 | PLATFORM Trial | 01 | N | FLUOROURACIL + RT | 101548771 |
| 20122293 | 20088985 | 1.54 | 84 | 03 | 2018-10-09 | 2018-10-13 | CARBOPLATIN + GEMCITABINE | 02 | N | FLUOROURACIL + RT | 100099904 |
| 20123736 | 20088987 | 1.83 | 45.8 | 03 | 2017-08-07 | 2017-08-20 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101188430 |
| 20124719 | 20088988 | 1.72 | null | null | 2020-03-07 | 2020-03-13 | Irinotecan | 02 | N | CISPLATIN + FLUORO + STREPTOZOCIN | 101383947 |
| 20124933 | 20088989 | 1.6 | 81.8 | 03 | 2018-10-07 | 2018-10-14 | PLATO Trials | 01 | N | PLATO TRIAL | 101624058 |
| 20128166 | 20088992 | null | 141 | Neo-adjuvant (N) | 2019-05-16 | 2019-05-16 | HEP HR Hepatoblastoma guide cisp | 01 | N | CETUXIMAB + RT | 101555987 |
| 20128607 | 20088993 | 1.63 | 64 | Palliative (P) | 2017-08-24 | 2017-08-27 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | ACALABRUTINIB | 101835170 |
| 20129164 | 20088994 | 1.63 | 74.19 | Palliative (P) | 2019-12-19 | 2020-01-10 | PEMBROLIZUMAB | Y | N | IBRUTINIB | 101311392 |
| 20130765 | 20088995 | 1.56 | 68 | Palliative (P) | 2018-10-14 | 2018-10-14 | CHOP R | 02 | null | GEMCARBO | 101675317 |
| 20133725 | 20088997 | 1.65 | 87.65 | 03 | 2019-01-02 | 2019-01-02 | FCarboSt | 02 | Y | IFOSFAMIDE | 101658038 |
| 20134501 | 20088998 | 0 | 0 | 03 | 2018-07-27 | 2018-08-30 | Capecitabine + Carboplatin + RT | 01 | N | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100943866 |
| 20135266 | 20088999 | 0 | 51 | null | null | 2019-08-22 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | N | CHOP R | 101265458 |
| 20137503 | 20089000 | 1.58 | 74 | Palliative (P) | 2019-10-11 | 2019-10-11 | Cetuximab + Radiotherapy Load | 02 | Y | GEMCITABINE + PACLITAXEL | 100743439 |
| 20141740 | 20089001 | 1.69 | 49.7 | Palliative (P) | 2020-06-20 | 2020-06-20 | Carbo F | N | N | PANITUMUMAB | 101510220 |
| 20141811 | 20089002 | null | 12.3 | null | 2017-07-17 | 2017-07-19 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101404764 |
| 20144981 | 20089004 | 1.54 | 70.4 | 03 | 2019-08-30 | 2019-09-06 | CARBOPLATIN + VINORELBINE | 02 | N | SCOPE2 TRIAL | 101092797 |
| 20145424 | 20089006 | 1.77 | 81 | null | 2015-04-28 | 2020-07-01 | R Chlorambucil | 02 | N | GO2 TRIAL | 101806526 |
| 20145785 | 20089007 | 0.85 | 64.6 | null | 2020-03-09 | 2020-04-21 | null | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101457750 |
| 20146565 | 20089008 | 1.6 | 63 | Palliative (P) | 2018-03-31 | 2018-04-04 | CVP R | 02 | N | SUNITINIB | 100751944 |
| 20148062 | 20089009 | 1.54 | 79.35 | 03 | 2019-11-28 | 2019-11-28 | null | 02 | N | CAPECITABINE + STREPTOZOCIN | 100374110 |
| 20148090 | 20089010 | 1.63 | 72.3 | null | 2017-02-06 | 2017-02-06 | Hydroxycarbamide | 02 | Y | ARISTOTLE TRIAL | 101403103 |
| 20151709 | 20089014 | 1.54 | 88 | 03 | 2020-03-29 | 2020-04-09 | ECarboF | 02 | N | PEMBROLIZUMAB | 100600019 |
| 20152132 | 20089015 | 1.7 | 81 | null | 2021-05-12 | 2021-05-12 | Paclitaxel 7 day | 02 | N | CNS ATRT DOX | 100979015 |
| 20153140 | 20089016 | 1.61 | 51.4 | null | 2019-04-12 | 2019-04-16 | ACELARATE Trial | 02 | Y | OXALIPLATIN | 100043799 |
| 20154672 | 20089018 | 1.45 | 64.6 | 03 | 2019-12-22 | 2020-01-09 | CAP + RT | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100611559 |
| 20154905 | 20089020 | 1.79 | null | 03 | 2018-12-11 | 2018-12-25 | MIC | 02 | N | RALTITREXED | 101838371 |
| 20155961 | 20089021 | 1.52 | 113 | 03 | 2019-10-14 | 2019-10-14 | CHOP R | 02 | N | FLUOROURACIL + STREPTOZOCIN | 101061155 |
| 20157609 | 20089022 | 1.56 | 58.6 | 03 | 2017-05-04 | 2017-05-04 | ACTICCA-1 Trial | 01 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100562124 |
| 20159240 | 20089023 | 1.7 | 85.2 | null | null | 2016-11-15 | Bevacizumab + Oxaliplatin +MdG | N | Y | AZACITIDINE | 101608329 |
| 20159329 | 20089024 | null | 69.8 | null | 2017-03-02 | 2017-03-07 | FCiSt | 02 | N | RALTITREXED | 100294437 |
| 20159425 | 20089025 | 1.58 | 55 | null | 2019-12-07 | 2019-12-07 | Bortezomib +/- Dexamethasone | 01 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101448302 |
| 20160123 | 20089026 | 1.78 | 66 | Palliative (P) | 2020-01-02 | 2020-01-04 | CAP + RT | 02 | N | EOF | 100490191 |
| 20160508 | 20089027 | 1.57 | 62.8 | 03 | 2018-06-17 | 2018-06-17 | OXALIPLATIN | 02 | N | PLATO TRIAL | 100589339 |
| 20165921 | 20089029 | 1.45 | 118 | Palliative (P) | 2019-02-01 | 2019-02-17 | Fluorouracil + Folinic + RT Bossett | N | N | LENALIDOMIDE | 100696463 |
| 20166245 | 20089030 | 1.82 | 109 | 03 | null | 2019-10-19 | OXALIPLATIN | N | N | DOXORUBICIN | 100000864 |
| 20166846 | 20089031 | null | 95.15 | Neo-adjuvant (N) | 2021-09-05 | 2021-09-06 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | OXALIPLATIN | 100349634 |
| 20175183 | 20089033 | 1.78 | 91 | Adjuvant (A) | 2019-09-07 | 2019-09-09 | ESPAC-4 TRIAL | 02 | N | NEO-AEGIS TRIAL | 101740273 |
| 20175995 | 20089034 | 1.62 | 96 | null | 2019-04-19 | 2019-04-28 | PLATO Trials | 02 | N | PLATO TRIAL | 100735644 |
| 20176608 | 20089035 | 1.64 | 79.6 | Palliative (P) | 2019-01-09 | 2019-01-27 | INTERAACT trial | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101408911 |
| 20176862 | 20089036 | 1.58 | 80.3 | null | 2014-12-12 | 2014-12-12 | Capecitabine + Streptozocin | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101290320 |
| 20183463 | 20089039 | 1.84 | 63 | 03 | 2016-09-11 | 2016-09-25 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | GO2 TRIAL | 101746146 |